Navinci Diagnostics
Latest round
- Series A
Last raised
- Jul 2022
Total raised
- $8.6M
Investors
- 4
About Navinci Diagnostics
Founded in 2004 by Ulf Landegren and Björn Ekström and based in Uppsala, Sweden, Navinci Diagnostics AB, formerly known as Olink Bioscience, engages in developing analytical methods for nucleic acids and proteins, spotting business prospects, and launching profitable products. In 2016, Olink Bioscience became Navinci Diagnostics. As of January 2023, Robert Gunnarsson serves as the CEO of the company. The company offers products such as NaveniFlex MR, NaveniFlex GM, NaveniFlex GR, NaveniFlex MM, NaveniFlex RR, and the NaveniFlex Control kit. It offers Naveni TriFlex Cell products, such as Naveni TriFlex Cell MR, and NaveniBright products, such as NaveniBright AP and NaveniBright HRP, as well as target-specific products, including Naveni PTMs (post-translational modifications) and Naveni PPIs (protein-protein interactions). The firm provides Naveni™ Proximity Ligation Technology platform, which provides accurate data with quantifiable and precise staining. Navinci's platform’s benefits include clear target detection, consistency in staining, reproducibility, the possibility to detect low abundance proteins, the detection of protein-protein interactions, and more.
Who invested in Navinci Diagnostics
4 investors across 1 round
See all investors in Navinci Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 12, 2022
Amount
$8.6M
Investors
Questions about Navinci Diagnostics
Who invested in Navinci Diagnostics?
Navinci Diagnostics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Navinci Diagnostics raised?
Navinci Diagnostics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Navinci Diagnostics last raise money?
Navinci Diagnostics's most recent round on record is a Series A, in Jul 2022.
What does Navinci Diagnostics do?
Founded in 2004 by Ulf Landegren and Björn Ekström and based in Uppsala, Sweden, Navinci Diagnostics AB, formerly known as Olink Bioscience, engages in developing analytical methods for nucleic acids and proteins, spotting business prospects, and launching profitable products.
Where is Navinci Diagnostics headquartered?
Navinci Diagnostics is headquartered in Uppsala, Sweden.
Which VCs invest in companies like Navinci Diagnostics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Navinci Diagnostics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Navinci Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.